Clinical Trial

Association of Biomarkers and Gastric Antral Motility Index With Feeding Intolerance in Critically Ill Patients

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 2, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
When the subjects are admitted to the department, the researchers will monitor potential biomarkers of gastrointestinal injury before administering enteral nutrition (a small amount of blood is drawn, serum is separated by centrifugation, and the serum sample is frozen for final centralized biomarker detection), and measure the antral movement index under ultrasound (300ml of warm water is injected into the stomach before measurement, and then the antral movement is observed for 6 minutes) Then, monitor whether the patient has developed feeding intolerance within 7 days of the ICU
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-10.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-29
Trial Details
NCT Number NCT07178626
Lead Sponsor The First Hospital of Jilin University
Conditions Critically Ill Patients Who Are Not Allowed to Eat Orally But Can Initiate Enteral Nutrition Within 48 Hours of ICU
Enrollment 160 participants
Start Date 2025-10-20
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-02